A 2-stage, Phase III study to investigate the efficacy and safety of anifrolumab in adults with chronic and/or subacute cutaneous lupus erythematosus

Trial Identifier: D346BC00001
Sponsor: AstraZeneca
Collaborator:
Parexel
NCTID:: NCT06015737
Start Date: June 2024
Primary Completion Date: January 2028
Study Completion Date: January 2028
Condition: Lupus

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
AR Ciudad de Buenos Aires, AR, 1221
AR Córdoba, AR, 5000
AR Quilmes, AR, 1878
AT Graz, AT, 8036
AT Innsbruck, AT, 6020
AT Linz, AT, 4020
AT Sankt Pölten, AT, 3100
AU Box Hill, AU, 3128
AU Clayton, AU, 3168
AU Melbourne, AU, 3004
AU Westmead, AU, 2145
AU Woolloongabba, AU, 04102
BE Liège, BE, 4000
BG Sofia, BG, 1784
BR Belo Horizonte, BR, 30150-221
BR Porto Alegre, BR, 90035903
BR Salvador, BR, 40150-150
CL Santiago, CL, 8420383
CN Baotou, CN, 14010
CN Beijing, CN, 100050
CN Beijing, CN, 100029
CN Changchun, CN, 130021
CN Chengdu, CN, 610021
CN Chongqing, CN, 400016
CN Guangzhou, CN, 510120
CN Hangzhou, CN, 310003
CN Heilongjiang, CN, 150086
CN Jinan, CN, 250022
CN Kunming, CN, 650101
CN Nanchang, CN, 330006
CN Nanjing, CN, 210042
CN Shanghai, CN, 200443
CN Shanghai, CN, 200025
CN Shenzhen, CN, 518020
CN Shijiazhuang, CN, 050000
CN Wuhan, CN, 430060
CO Barranquilla, CO, 01800
CO Bogota, CO, 110221
CO Chia, CO, 250001
DE Berlin, DE, 10117
DE Bochum, DE, 44791
DE Dresden, DE, 01307
DE Hannover, DE, 30625
DE Kiel, DE, 24105
DE Leipzig, DE, 04103
DE Mainz, DE, 55131
DE Regensburg, DE, 93053
DE Wuppertal, DE, 42283
DK København, DK, 2100
ES Barcelona, ES, 8035
ES Barcelona, ES, 08025
ES Madrid, ES, 28006
ES Madrid, ES, 28041
ES Madrid, ES, 28034
FR Bois Guillaume, FR, 76031
FR Chambray Les Tours, FR, 37170
FR LILLE CEDEX, FR, 59037
FR LYON CEDEX 03, FR, 69437
FR NICE, FR, 06200
FR Paris, FR, 75970
FR Paris, FR, 75013
FR Paris, FR, 75010
FR PARIS, FR, 75014
FR TOULOUSE CEDEX 9, FR, 31059
GB Cambridge, GB, CB2 0QQ
GB Leeds, GB, LS2 9JT
GB London, GB, SE1 7EH
GB London, GB, NW1 2PG
GB London, GB, SE5 9RS
GR Athens, GR, 12462
GR Athens, GR, 16121
GR Athens, GR, 11527, GR
IT Brescia, IT, 25123
IT Florence, IT, 50121
IT NAPOLI, IT, 80138
IT Rome, IT, 00168
IT Torrette, IT, 60126
JP Fukuoka-Shi, JP, 812-8582
KR Seoul, KR, 06973
KR Seoul, KR, 03080
MX Guadalajara, MX, 44340
MX Guadalajara, MX, 44690
NL Rotterdam, NL, 3015 GD
PH Iloilo City, PH, 5000
PH Lipa, PH, 4217
PH Manila, PH, 1000
PL Katowice, PL, 40-851
PL Olsztyn, PL, 30-229
PL Poznan, PL, 60-529
PL Warszawa, PL, 02-507
PL Warszawa, PL, 01-157
RS Kragujevac, RS, 34000
TW Kaohsiung, TW, 83301
TW Taichung, TW, 404
US, AZ Glendale, AZ, US, 85306
US, AZ Phoenix, AZ, US, 85028
US, CA La Jolla, CA, US, 92037
US, CA Orange, CA, US, 92868
US, CT New Haven, CT, US, 06519
US, FL Fort Lauderdale, FL, US, 33309
US, FL Miami, FL, US, 33174
US, FL Miami, FL, US, 33136
US, FL Plantation, FL, US, 33324
US, Massachusetts Boston, Massachusetts, US, 02115-5817
US, MI Ann Arbor, MI, US, 48109
US, NY Brooklyn, NY, US, 11201
US, NY Rochester, NY, US, 14642
US, OH Cleveland, OH, US, 44195
US, OR Portland, OR, US, 97239
US, Virginia Charlottesville, Virginia, US, 22903
ZA Cape Town, ZA, 7500
ZA Johannesburg, ZA, 2193